Pseudo-Gaucher histiocytes identified up to 1 year after transplantation for CML are BCR/ABL-positive

Leukemia

Volumn 12, Issue 2, 1998, Pages 233-237

  Anastasi, J ^a   Musvee, T ^a   Roulston, D ^a   Domer, P H ^a   Larson, R A ^a   Vardiman, J W ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

BCR ABL; CML; In situ hybridization; PCR; Pseudo Gaucher cells; Residual disease

Indexed keywords

BCR ABL PROTEIN; DNA;

ADULT; ARTICLE; BONE MARROW BIOPSY; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GAUCHER DISEASE; HISTIOCYTE; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; MALE; PHILADELPHIA 1 CHROMOSOME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; STEM CELL TRANSPLANTATION;

EID: 0031910412     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400900     Document Type: Article

References (22)

1. Albrecht M, 'Gaucher-Zellen' bei chronisch myeloischer Leukämie. Blut 1966; 13: 169-179.
2. Dosik H, Rosner F, Sawitsky A. Acquired lipidosis: Gaucher-like cells and 'blue-cells' in chronic granulocytic leukaemia. Semin Haematol 1972; 9: 309-316.
3. Kelsey PR, Geary CG. Sea-blue histiocytes and Gaucher cells in bone marrow of patients with chronic myeloid leukaemia. J Clin Pathol 1988; 41: 960-962.
4. Kattlove HE, Williams JC, Gaynor E, Spivac M, Bradley RM, Brady RO. Gaucher cells in chronic myelocytic leukemia: an acquired abnormality. Blood 1969; 33: 379-390.
5. Sawyers CL, Timson L, Kawasaki ES, Clark SS, Witte O, Champlin R. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87: 563-567.
6. Kohler S, Galili N, Sklar JL, Donlon TA, Blume KG, Cleary ML. Expression of bcr-abl fusion transcripts follow bone marrow transplantation for Philadelphia chromosome-positive leukemia. Leukemia 1990; 4: 541-547.
7. Delage R, Soiffer RJ, Dear K, Ritz J. Clinical significance of bcr-dbl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia. Blood 1991; 78: 2759-2767.
8. Roth MS, Antin JH, Ash R, Terry VH, Gotlieb M, Silver SM, Ginsburg D. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allog- eneic bone marrow transplant for chronic myelogenous leukemia. Blood 1992; 79: 276-282.
9. Cross NCP, Hughes TP, Feng L, O'Shea P, Bungey J, Marks DI, Ferrant A, Martiat P, Goldman JM. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. Br J Haematol 1993; 84: 67-74.
10. Miyamura K, Tahara T, Tanimoto M, Morishita Y, Kawashima K, Morishima Y, Saito H, Tsuzuki S, Takeyama K, Kodera Y. Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients. Blood 1993; 81: 1089-1093.
11. Miyamura K, Barrett AJ, Kodera Y, Saito H. Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemic effect: a review of recent results. Bone Marrow Transplant 1994; 14: 201-209.
12. Radich JP, Gehly G, Gooley T, Bryant E, Cliff RA, Collins S, Edmands S, Kirk J, Lee A, Kessler P. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allgoeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood 1995; 85: 2632-2638.
13. Anastasi J, Vardiman JW, Rudinsky R, Patel M, Nachman J, Rubin CM, Le Beau MM. Direct correlation of cytogenetic findings with cell morphology by in situ hybridization: an analysis of suspicious cells from bone marrow specimens of two patients completing therapy for lymphoblastic leukemia. Blood 1991; 77: 2456-2462.
14. Anastasi J, Feng J, Le Beau MM, Larson RA, Rowley JD, Vardiman JW. Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factors, and clone expansion. Blood 1993; 81: 1580-1585.
15. Dewald GW, Schad CR, Christensen ER, Tiede AL, Zinsmeister AR, Spurbeck JL, Thibodeau SN, Jalal SM. The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL. Cancer Genet Cytogenet 1993; 71: 7-14.
16. + acute lymphoblastic leukemia. Leukemia 1996; 10: 795-802.
17. Golde DW, Burgaleta C, Sparkes RS, Cline MJ. The Philadelphia chromosome in human macrophages. Blood 1977; 49: 367-370.
18. Ely P, Haase A, Wietgrefe S, Zupancic M, Beneke J, Hertz M, Miller W. A new in situ hybridization technique for spliced RNA species documents the bone marrow origin of pulmonary macrophages in chronic myelogenous leukemia. Blood 1992; 80; 2321-2325.
19. Hayhoe FGJ, Flemans RJ. Color Atlas of Hematologic Cytology (2nd edn). Wiley: New York, 1982, pp65.
20. Bain BJ. Blood Cells: A Practical Guide (2nd edn). Blackwell: London, 1995, pp94.
21. Lion T, Gaiger A, Henn T, Horth E, Haas OA, Geissler K, Gadner H. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon. Leukemia 1995; 9: 1353-1360.
22. Lin F, van Rhee F, Goldman JM, Cross NCP. Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. Blood 1996; 87: 4473-4478.